13F Data
13F filer · CIK 1579853

SENZAR ASSET MANAGEMENT, LLC

New York, NY · filing since Q4 2013 · last filing Oct 31, 2018
Reported value
$406.2M
+$11.5M vs prior
Positions
23
New / sold out
7 / 12
Added / reduced
8 / 8
Turnover
45.9%
buys $189.7M · sells $183.8M
Top-10 weight
76.7%

Biggest buys vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
NewNEUROCRINE BIOSCIENCES INC+749,200–+$34.5M
NewLLYLILLY ELI & CO+415,200–+$34.2M
AddedMYLAN N V+690,400+318.6%+$26.8M
NewAERIE PHARMACEUTICALS INC+391,400–+$20.6M
NewCVSCVS HEALTH CORP+226,600–+$18.2M
NewDAVITA INC+258,800–+$16.8M
AddedHALOZYME THERAPEUTICS INC+597,400+17.1%+$7.7M
AddedEXPRESS SCRIPTS HLDG CO+118,000+22.5%+$7.5M
NewACHILLION PHARMACEUTICALS IN+1,082,100–+$5.0M
AddedALDER BIOPHARMACEUTICALS INC+342,700+159.3%+$3.9M
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
Sold outSANOFI-1,538,908-100.0%$-69.6M
Sold outBIOVERATIV INC-343,800-100.0%$-18.7M
Sold outMIMEDX GROUP INC-1,692,850-100.0%$-16.1M
Sold outGLOBUS MED INC-447,100-100.0%$-13.2M
Sold outMYRIAD GENETICS INC-518,800-100.0%$-10.0M
Sold outSELECT MED HLDGS CORP-662,200-100.0%$-8.8M
Sold outTENET HEALTHCARE CORP-484,300-100.0%$-8.6M
Sold outORTHOFIX INTL N V-188,908-100.0%$-7.2M
Sold outDIPLOMAT PHARMACY INC-445,200-100.0%$-7.1M
ReducedCORIUM INTL INC-704,500-46.7%$-5.3M
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $122.4MQ1 2014: $188.8MQ2 2014: $261.8MQ3 2014: $341.0MQ4 2014: $341.2MQ1 2015: $410.3MQ2 2015: $582.4MQ3 2015: $687.5MQ4 2015: $899.4MQ1 2016: $503.7MQ2 2016: $459.0MQ3 2016: $386.8MQ4 2016: $377.1MQ1 2017: $394.7MQ2 2017: $406.2MQ3 2017: $409.7MQ4 2017: $391.7MQ1 2018: $316.9MQ2 2018: $34.7MQ3 2018: $0
Q4 2013Q3 2018

Holdings · Q2 2017

#SecuritySharesValueWeight
1HALOZYME THERAPEUTICS INCCOM4,087,264$52.4M12.90%
2EXPRESS SCRIPTS HLDG COCOM641,301$40.9M10.08%
3MYLAN N VSHS EURO907,100$35.2M8.67%
4NEUROCRINE BIOSCIENCES INCCOM749,200$34.5M8.49%
5LLYLILLY ELI & CO415,200$34.2M8.41%
6ANTHEM INCCOM144,350$27.2M6.69%
7GILEAD SCIENCES INCCOM373,800$26.5M6.51%
8ABBOTT LABSCOM450,700$21.9M5.39%
9AERIE PHARMACEUTICALS INCCOM391,400$20.6M5.06%
10CVSCVS HEALTH CORP226,600$18.2M4.49%
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.